146 related articles for article (PubMed ID: 35404907)
1. The Strange Case of a Pancreatic Neuroendocrine Carcinoma With Low Proliferation Index and Atypical Clinical Behavior.
Feola T; Centello R; Sesti F; Puliani G; Verrico M; Di Vito V; Di Gioia C; Bagni O; Pisegna S; Lenzi A; Isidori AM; Giannetta E; Faggiano A
Pancreas; 2022 Feb; 51(2):e25-e27. PubMed ID: 35404907
[No Abstract] [Full Text] [Related]
2. Poorly Differentiated and Undifferentiated Pancreatic Neuroendocrine Carcinoma Management and Outcomes: A Surveillance, Epidemiology, and End Results Assessment.
Gan Y; Su S; Fang C; Li C; Wen TF
Pancreas; 2022 Apr; 51(4):e64-e65. PubMed ID: 35687071
[No Abstract] [Full Text] [Related]
3. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
Konukiewitz B; Jesinghaus M; Kasajima A; Klöppel G
Virchows Arch; 2022 Feb; 480(2):247-257. PubMed ID: 34647171
[TBL] [Abstract][Full Text] [Related]
5. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
6. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
Kim D; Viswanathan K; Goyal A; Rao R
Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
[TBL] [Abstract][Full Text] [Related]
7. TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience.
Sellner F; Thalhammer S; Stättner S; Karner J; Klimpfinger M
J Surg Oncol; 2011 Jul; 104(1):17-21. PubMed ID: 21360536
[TBL] [Abstract][Full Text] [Related]
8. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
Sorbye H; Baudin E; Perren A
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous primary hepatocellular carcinoma and neuroendocrine carcinoma.
Mita H; Adachi Y; Ishii Y; Endo T
Dig Liver Dis; 2021 Jun; 53(6):792-793. PubMed ID: 32593515
[No Abstract] [Full Text] [Related]
10. Pancreatic neuroendocrine tumor mimicking a malignant intraductal papillary mucinous neoplasm.
Kirchgesner J; Colignon N; Balladur P; Fléjou JF; Svrcek M
Pancreatology; 2016; 16(2):290-2. PubMed ID: 26948577
[No Abstract] [Full Text] [Related]
11. Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine pancreatic tumors].
Knast W; Markocka-Maczka K; Rabczyński J; Zabel M
Wiad Lek; 2003; 56(9-10):486-90. PubMed ID: 15049216
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon.
La Salvia A; Persano I; Parlagreco E; Audisio A; Cani M; Brizzi MP
Med Oncol; 2022 Aug; 39(11):168. PubMed ID: 35972607
[TBL] [Abstract][Full Text] [Related]
14. Paraduodenal/pancreatic Ewing sarcoma is very rare and therefore may be mistaken for neuroendocrine carcinoma.
Wong NACS; Suortamo S; George E; Beavers S
J Clin Pathol; 2022 Jan; 75(1):71-72. PubMed ID: 33619219
[No Abstract] [Full Text] [Related]
15. Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.
Hunt JL; Barnes L; Triantafyllou A; Gnepp DR; Devaney KO; Stenman G; Halmos GB; Bishop JA; Skálová A; Willems SM; Hellquist H; Rinaldo A; Ferlito A
Adv Anat Pathol; 2019 Jul; 26(4):246-250. PubMed ID: 31033507
[TBL] [Abstract][Full Text] [Related]
16. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
[TBL] [Abstract][Full Text] [Related]
17. High-grade transformation of pancreatic neuroendocrine tumor associated with TP53 mutations: A diagnostic pitfall mimicking neuroendocrine carcinoma.
Tanaka M; Shinozaki-Ushiku A; Kunita A; Yasunaga Y; Akamatsu N; Hasegawa K; Ushiku T
Pathol Int; 2022 Aug; 72(8):411-418. PubMed ID: 35698921
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
Takahashi K; Ozawa E; Nakao K; Aoki S; Takase Y
J Gastroenterol Hepatol; 2019 Jun; 34(6):964. PubMed ID: 30663800
[No Abstract] [Full Text] [Related]
19. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
20. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
